Pharmaceutical companies are crossing borders around the globe, leading many to seek the best markets for expansion. Japan is often at the top of that list. As the second largest pharma market in the world, Japan offers advantages from universal healthcare coverage to extended patent cycles to government support of innovation.
Entering the Japanese market, however, requires a clear understanding of the unique regulatory requirements and advantages of conducting clinical development in Japan.
Quintiles’ local In-Country Clinical Caretaker (ICCC) team can help you directly conduct clinical trials in Japan as the drug sponsor. It’s the option that allows you to retain control and minimize risk.